News

Multiple clinical trials and pilot programs underscore growing interest in wireless patient monitoring technology Preventice, Inc., a leading developer of mHealth solutions, announced the commercial availability of its BodyGuardian Remote...

In May 2013, Andrea Natale, M.D., F.H.R.S., F.A.C.C., F.E.S.C., cardiac electrophysiologist and executive medical director of the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center, celebrates five years of leadership at...

Endosense, a pioneer and leader in contact force (CF) technology focused on improving the efficacy and safety of catheter ablation for the treatment of cardiac arrhythmias, further advanced its leadership position in the field with new study...

Industry-Leading Battery Life Reduces the Frequency of Replacement Surgery New data from 100,438 patients with Boston Scientific Corporation implantable cardiac defibrillators (ICDs) and cardiac resynchronization therapy defibrillators...

BioControl Medical has unveiled a new corporate website that offers patients, family and clinicians a valuable educational resource on its CardioFit therapy for heart failure (HF), as well as the INOVATE-HF (INcrease Of VAgal TonE in Heart...

Company Offers Mapping System with IntellaMap Orion™ Mapping Catheter in Effort to Significantly Enhance Physician Treatment Options Boston Scientific Corporation has received CE Mark approval for the Rhythmia™ Mapping System, a...

Nanostim, Inc., a privately-owned developer of miniaturized, leadless cardiac pacemakers (LCP), announced preliminary results from its LEADLESS study during the late breaking clinical trial presentations at Heart Rhythm 2013, the Heart Rhythm...

Next-generation implantable defibrillators feature additional safety features to elevate the standard of care St. Jude Medical, Inc., a global medical device company, announced CE Mark approval of its next-generation Ellipse™ and SJM Assura™...

New Data in High Risk Patients Presented at Heart Rhythm Society Shows a 70% Reduction in CIED Infections Use of TYRX, Inc.’s AIGISRx® Antibacterial Envelope significantly reduced device infection rates in patients at high risk for device...

Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, announced it received FDA approval for and is beginning the U.S. launch of the SMARTVIEW™ remote monitoring solution for patients with implanted...